The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
出版年份 2016 全文链接
标题
The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 19, Issue 12, Pages pyw068
出版商
Oxford University Press (OUP)
发表日期
2016-08-05
DOI
10.1093/ijnp/pyw068
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference
- (2014) Shiva Hashemizadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- NESS06SM reduces body weight with an improved profile relative to SR141716A
- (2013) Andrea Mastinu et al. PHARMACOLOGICAL RESEARCH
- Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach
- (2013) Bernard Le Foll et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile
- (2012) Andrea Mastinu et al. BEHAVIOURAL BRAIN RESEARCH
- Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
- (2012) F J Meye et al. MOLECULAR PSYCHIATRY
- Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability
- (2012) Lesley D. O'Brien et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking
- (2011) Islam Gamaleddin et al. ADDICTION BIOLOGY
- SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats
- (2010) N.M.W.J. de Bruin et al. BEHAVIOURAL BRAIN RESEARCH
- Granular Insular Cortex Inactivation as a Novel Therapeutic Strategy for Nicotine Addiction
- (2010) Benoit Forget et al. BIOLOGICAL PSYCHIATRY
- Depression-like phenotype following chronic CB1 receptor antagonism
- (2010) Chad E. Beyer et al. NEUROBIOLOGY OF DISEASE
- The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
- (2010) Nina L. Cluny et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
- (2009) David R Janero et al. EXPERT OPINION ON EMERGING DRUGS
- The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking
- (2009) Maram A. T. M. Khaled et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats
- (2009) Anh Dzung Lê et al. PSYCHOPHARMACOLOGY
- Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
- (2009) K. S. Sink et al. PSYCHOPHARMACOLOGY
- Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration—comparison with CB1 receptor blockade
- (2009) Benoit Forget et al. PSYCHOPHARMACOLOGY
- The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats
- (2008) Janel Hodge et al. BEHAVIOURAL BRAIN RESEARCH
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †
- (2008) Luc F. Van Gaal et al. EUROPEAN HEART JOURNAL
- The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence
- (2008) L. L. Merritt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects
- (2008) Huibing Tan et al. NEUROPHARMACOLOGY
- Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
- (2008) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats
- (2007) Mohammed Shoaib NEUROPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More